ECCO 2025 Preview: Key Crohn’s and Colitis Highlights to Watch
ECCO 2025 at a glance As ECCO 2025 approaches, LucidQuest summarizes the…
IMCAS 2025 Preview: Key Aesthetic Medicine Highlights to Watch
IMCAS 2025 at a glance Prepare for IMCAS 2025 with LucidQuest’s preview,…
AI-Powered Medical Affairs: Enhancing value, engagement, and insights
The pharmaceutical sector is witnessing a transformative shift fueled by the…
Unveiling the Financial Ties: HCPs, PAOs and Pharmaceutical Funding
The entanglement of financial relationships among healthcare professionals…
New antibiotics on the way: How pharma can tackle the Antimicrobial Resistance crisis
The overuse and misuse of antimicrobials in humans and animals have escalated…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
The Next Frontier: Pharma and Longevity
From The Epic of Gilgamesh, the earliest surviving book, to the controversial…
mRNA personalized Cancer Vaccines: BioNTech and Moderna Race to the Finish Line
With the emergence of immunotherapy for oncology, cancer vaccines are cropping…
Cell and Gene Therapy Clinical Trials – 2024 Edition
Gene therapy clinical trials promise transformative breakthroughs in treating…
From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
Navigating the Immunoglobulin Therapy Landscape: An Overview
The Immunoglobulin Replacement Therapy (IG) market is growing, as these…
